GSK983
SIGMA/SML1824 - ≥98% (HPLC)
Synonym: GSK260983; N-
CAS Number: 827591-02-6
Empirical Formula (Hill Notation): C18H16ClN3O
Molecular Weight: 325.79
MDL Number: MFCD28978021
Linear Formula: C18H16ClN3O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H16ClN3O/c19-11-7-8 |
| InChI key | WJQBOBGVBBZLJU-UHFFFAOYSA |
| optical activity | [α]/D +175 to +195°, c = 1 in methylene chloride |
| Quality Level | 100 ![]() |
| SMILES string | ClC1=CC=C(NC2=C3CCC[C@H]2 |
| solubility | DMSO: 10 mg/mL, clear |
| storage condition | protect from light |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | GSK983 blocks RNA virus replication with EC50 values of 10–40 nM, and also blocks cell proliferation. |
| Biochem/physiol Actions: | GSK983 blocks RNA virus replication with EC50 values of 10–40 nM, and also blocks cell proliferation. GSK983 acts by inhibition of dihydroorotate dehydrogenase (DHODH), necesssary for pyrimidine biosynthesis. Exogenous deoxycytidine was able to reduce GSK983 cytotoxicity, allowing cells to synthesize DNA, but still preventing RNA virus replication. GSK983 was active against dengue fever and Venezuelan equine encephalitis viruses. |
| Biochem/physiol Actions: | GSK983 is a tetrahydrocarbazole or a broad spectrum antiviral lead compound. GSK983 acts by stimulating a subset of interferon-stimulated genes. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 |
| Precautionary statements | P301 + P312 + P330 - P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |


